help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Teixeira, C.
Right arrow Articles by Pratt, M. A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Teixeira, C.
Right arrow Articles by Pratt, M. A. C.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Breast Cancer
Hazardous Substances DB
*TRANS-RETINOIC ACID
Molecular Endocrinology 11 (9): 1191-1202
Copyright © 1997 by The Endocrine Society

CDK2 Is a Target for Retinoic Acid-Mediated Growth Inhibition in MCF-7 Human Breast Cancer Cells

Christine Teixeira and M. A. Christine Pratt

Department of Pharmacology University of Ottawa Ottawa, Ontario, Canada, K1H 8M5

Retinoic acid (RA) inhibition of breast cancer cell growth is associated with an accumulation of cells in G1 phase of the cell cycle. We have investigated the effects of RA on the expression and activity of cell cycle-regulatory proteins in MCF-7 human breast cancer cells. Flow cytometry analysis of MCF-7 cells treated with RA revealed a decrease in the percentage of cells in S phase by 48 h, which was maximal by 72 h. Phosphorylation of the retinoblastoma protein (pRb) was partially reduced in RA-treated cells accompanied by a decrease in the level of retinoblastoma protein. Expression of the cyclin D1 transcript was reduced by 48 h and cyclin-dependent kinase 2 (cdk2) mRNA levels declined within 8 h posttreatment followed by a decrease in cyclin D1 and cdk2 protein levels. Message and protein levels of cdk4 and cdc2 were not affected by RA. While cdk4 activity was similar in control and RA-treated cells, cdk2 activity began to decrease within 48 h of exposure to RA and was profoundly reduced after 72 h. This reduced activity was associated with decreased phosphorylation of cdk2. The decrease in cdk2 activity occurred in the absence of RA-mediated increases in the levels of the cdk inhibitors p21and p27. However, assays of cdk2 from pooled lysates from RA-treated and control cells showed that RA-treated cells contain a cdk2-inhibitory activity. Our results show that RA inhibits cell cycle progression of MCF-7 cells by inhibiting cdk2 mRNA and protein production and by decreasing cdk2 activity.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
T. Kogai, E. Ohashi, M. S. Jacobs, S. Sajid-Crockett, M. L. Fisher, Y. Kanamoto, and G. A. Brent
Retinoic Acid Stimulation of the Sodium/Iodide Symporter in MCF-7 Breast Cancer Cells Is Meditated by the Insulin Growth Factor-I/Phosphatidylinositol 3-Kinase and p38 Mitogen-Activated Protein Kinase Signaling Pathways
J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1884 - 1892.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. J. Donato, J. H. Suh, and N. Noy
Suppression of Mammary Carcinoma Cell Growth by Retinoic Acid: the Cell Cycle Control Gene Btg2 Is a Direct Target for Retinoic Acid Receptor Signaling
Cancer Res., January 15, 2007; 67(2): 609 - 615.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. C. He, T.-C. Lu, M. Fleet, M. Sunamoto, M. Husain, W. Fang, S. Neves, Y. Chen, S. Shankland, R. Iyengar, et al.
Retinoic Acid Inhibits HIV-1-Induced Podocyte Proliferation through the cAMP Pathway
J. Am. Soc. Nephrol., January 1, 2007; 18(1): 93 - 102.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Belosay, A. M.H. Brodie, and V. C.O. Njar
Effects of Novel Retinoic Acid Metabolism Blocking Agent (VN/14-1) on Letrozole-Insensitive Breast Cancer Cells
Cancer Res., December 1, 2006; 66(23): 11485 - 11493.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. Tagliati, M. C. Zatelli, A. Bottoni, D. Piccin, A. Luchin, M. D. Culler, and E. C. degli Uberti
Role of Complex Cyclin D1/Cdk4 in Somatostatin Subtype 2 Receptor-Mediated Inhibition of Cell Proliferation of a Medullary Thyroid Carcinoma Cell Line in Vitro
Endocrinology, July 1, 2006; 147(7): 3530 - 3538.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Y. Park, A. Dillard, E. A. Williams, E. T. Wilder, M. R. Pepper, and M. A. Lane
Retinol Inhibits the Growth of All-Trans-Retinoic Acid-Sensitive and All-Trans-Retinoic Acid-Resistant Colon Cancer Cells through a Retinoic Acid Receptor-Independent Mechanism
Cancer Res., November 1, 2005; 65(21): 9923 - 9933.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Dentice, C. Luongo, A. Elefante, R. Romino, R. Ambrosio, M. Vitale, G. Rossi, G. Fenzi, and D. Salvatore
Transcription Factor Nkx-2.5 Induces Sodium/Iodide Symporter Gene Expression and Participates in Retinoic Acid- and Lactation-Induced Transcription in Mammary Cells
Mol. Cell. Biol., September 15, 2004; 24(18): 7863 - 7877.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Vuocolo, E. Purev, D. Zhang, J. Bartek, K. Hansen, D. R. Soprano, and K. J. Soprano
Protein Phosphatase 2A Associates with Rb2/p130 and Mediates Retinoic Acid-induced Growth Suppression of Ovarian Carcinoma Cells
J. Biol. Chem., October 24, 2003; 278(43): 41881 - 41889.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M.A. C. Pratt and M.-Y. Niu
Bcl-2 Controls Caspase Activation Following a p53-dependent Cyclin D1-induced Death Signal
J. Biol. Chem., April 11, 2003; 278(16): 14219 - 14229.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Qin, R. Burghardt, R. Smith, M. Wormke, J. Stewart, and S. Safe
Peroxisome Proliferator-activated Receptor {gamma} Agonists Induce Proteasome-dependent Degradation of Cyclin D1 and Estrogen Receptor {alpha} in MCF-7 Breast Cancer Cells
Cancer Res., March 1, 2003; 63(5): 958 - 964.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. Nabeyrat, S. Corroyer, R. Epaud, V. Besnard, V. Cazals, and A. Clement
Retinoic acid-induced proliferation of lung alveolar epithelial cells is linked to p21CIP1 downregulation
Am J Physiol Lung Cell Mol Physiol, January 1, 2000; 278(1): L42 - L50.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Sueoka, H.-Y. Lee, G. L. Walsh, W. K. Hong, and J. M. Kurie
Posttranslational Mechanisms Contribute to the Suppression of Specific Cyclin: CDK Complexes by All-Trans Retinoic Acid in Human Bronchial Epithelial Cells
Cancer Res., August 1, 1999; 59(15): 3838 - 3844.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Kaiser, F. H. Brembeck, B. Nicke, B. Wiedenmann, E.-O. Riecken, and S. Rosewicz
All-trans-Retinoic Acid-mediated Growth Inhibition Involves Inhibition of Human Kinesin-related Protein HsEg5
J. Biol. Chem., July 2, 1999; 274(27): 18925 - 18931.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. M. Cover, S. J. Hsieh, S. H. Tran, G. Hallden, G. S. Kim, L. F. Bjeldanes, and G. L. Firestone
Indole-3-carbinol Inhibits the Expression of Cyclin-dependent Kinase-6 and Induces a G1 Cell Cycle Arrest of Human Breast Cancer Cells Independent of Estrogen Receptor Signaling
J. Biol. Chem., February 13, 1998; 273(7): 3838 - 3847.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Kogai, J. J. Schultz, L. S. Johnson, M. Huang, and G. A. Brent
Retinoic acid induces sodium/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line
PNAS, July 18, 2000; 97(15): 8519 - 8524.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society